6 research outputs found
Recommended from our members
Automated motion artifact removal for intravital microscopy, without a priori information
Intravital fluorescence microscopy, through extended penetration depth and imaging resolution, provides the ability to image at cellular and subcellular resolution in live animals, presenting an opportunity for new insights into in vivo biology. Unfortunately, physiological induced motion components due to respiration and cardiac activity are major sources of image artifacts and impose severe limitations on the effective imaging resolution that can be ultimately achieved in vivo. Here we present a novel imaging methodology capable of automatically removing motion artifacts during intravital microscopy imaging of organs and orthotopic tumors. The method is universally applicable to different laser scanning modalities including confocal and multiphoton microscopy, and offers artifact free reconstructions independent of the physiological motion source and imaged organ. The methodology, which is based on raw data acquisition followed by image processing, is here demonstrated for both cardiac and respiratory motion compensation in mice heart, kidney, liver, pancreas and dorsal window chamber
Recommended from our members
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Background—Myocardial infarction (MI) is an ischemic wound that recruits millions of leukocytes. MI-associated blood leukocytosis correlates inversely with patient survival, yet the signals driving heightened leukocyte production after MI remain incompletely understood.
Methods and Results—With the use of parabiosis surgery, this study shows that soluble danger signals, among them interleukin-1β, increase bone marrow hematopoietic stem cell proliferation after MI. Data obtained in bone marrow reconstitution experiments reveal that interleukin-1β enhances hematopoietic stem cell proliferation by both direct actions on hematopoietic cells and through modulation of the bone marrow’s hematopoietic microenvironment. An antibody that neutralizes interleukin-1β suppresses these effects. Anti-interleukin-1β treatment dampens the post-MI increase in hematopoietic stem cell proliferation. Consequently, decreased leukocyte numbers in the blood and infarct reduce inflammation and diminish post-MI heart failure in ApoE–/– mice with atherosclerosis.
Conclusions—The presented insight into post-MI bone marrow activation identifies a mechanistic target for muting inflammation in the ischemically damaged heart
In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing
Objectives
The aim of this study was to test whether silencing of the transcription factor interferon regulatory factor 5 (IRF5) in cardiac macrophages improves infarct healing and attenuates post–myocardial infarction (MI) remodeling.
Background
In healing wounds, the M1 toward M2 macrophage phenotype transition supports resolution of inflammation and tissue repair. Persistence of inflammatory M1 macrophages may derail healing and compromise organ functions. The transcription factor IRF5 up-regulates genes associated with M1 macrophages.
Methods
Here we used nanoparticle-delivered small interfering ribonucleic acid (siRNA) to silence IRF5 in macrophages residing in MIs and in surgically-induced skin wounds in mice.
Results
Infarct macrophages expressed high levels of IRF5 during the early inflammatory wound-healing stages (day 4 after coronary ligation), whereas expression of the transcription factor decreased during the resolution of inflammation (day 8). Following in vitro screening, we identified an siRNA sequence that, when delivered by nanoparticles to wound macrophages, efficiently suppressed expression of IRF5 in vivo. Reduction of IRF5 expression, a factor that regulates macrophage polarization, reduced expression of inflammatory M1 macrophage markers, supported resolution of inflammation, accelerated cutaneous and infarct healing, and attenuated development of post-MI heart failure after coronary ligation as measured by protease targeted fluorescence molecular tomography–computed tomography imaging and cardiac magnetic resonance imaging (p < 0.05).
Conclusions
This work identified a new therapeutic avenue to augment resolution of inflammation in healing infarcts by macrophage phenotype manipulation. This therapeutic concept may be used to attenuate post-MI remodeling and heart failure.National Heart, Lung, and Blood Institute (Contract HHSN268201000044C)National Heart, Lung, and Blood Institute (Grant R01-HL096576)National Heart, Lung, and Blood Institute (Grant R01-HL095629)National Heart, Lung, and Blood Institute (Grant R01-HL114477
Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction
PF-1355 is an oral myeloperoxidase (MPO) inhibitor that successfully decreased elevated MPO activity in mouse myocardial infarction models. Short duration PF-1355 treatment for 7 days decreased the number of inflammatory cells and attenuated left ventricular dilation. Cardiac function and remodeling improved when treatment was increased to 21 days. Better therapeutic effect was further achieved with early compared with delayed treatment initiation (1 h vs. 24 h after infarction). In conclusion, PF-1355 treatment protected a mouse heart from acute and chronic effects of MI, and this study paves the way for future translational studies investigating this class of drugs in cardiovascular diseases
Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells
Few studies have directly compared the efficiencies of
gene delivery methods that target normal lung cells versus
lung tumor cells. We report the first study directly
comparing the efficiency and toxicity of viral [adenoassociated
virus (AAV2, 5, 6) and lentivirus], nonviral
(Effectene, SuperFect and Lipofectamine 2000) and
physical [particle-mediated gene transfer (PMGT)]
methods of gene delivery in normal mouse lung cells and
in mouse adenocarcinoma cells. Lentivirus pseudotyped
with the vesicular stomatitis virus glycoprotein was the
most efficient gene transfer method for normal mouse
airway epithelial cells [25.95 ( ± 3.57) %] whereas AAV6
was most efficient for MLE-12 adenocarcinoma cells [68.2
(± 3.2) %]. PMGT was more efficient in normal mouse
airway epithelial cells than AAV5, Lipofectamine 2000 and
SuperFect. AAV5 displayed the lowest transfection
efficiency at less than 10% in both cell types. PMGT was
the only method that resulted in significant toxicity. In
summary, for all of the gene delivery methods examined
here, lung tumor cells were transfected more easily than
normal lung cells. Lipofectamine 2000 is potentially
highly selective for lung tumor cells whereas AAV6 and
lentivirus vesicular stomatitis virus glycoprotein may be
useful for gene delivery strategies that require targeting
of both normal and tumor cell